Literature DB >> 32851502

Long-term outcome of patients with primary or secondary tumors of the proximal femur treated by bipolar modular tumor prosthesis.

Wessam Gamal Abou Senna1, Walid Atef Ebeid1, Mohamed Abdel Moneim1, Mostafa Saladin1, Bahaa Zakarya Hasan2, Ismail Tawfeek Badr2, Mahmoud Abdel Karim3.   

Abstract

PURPOSE: The proximal femur is a common area for primary and also metastatic bone tumors. The objective of this study was to assess the long-term functional and oncological outcomes of patients with malignant primary or secondary tumors of the proximal femur, who underwent proximal femoral resection then reconstruction using bipolar modular tumor prosthesis.
METHODS: Sixty patients with proximal femoral malignant tumors underwent resection and bipolar modular prosthesis between 2000 and 2016, were retrospectively reviewed. Based on diagnosis and presence or absence of pathological fracture, patients were divided into groups. The functional outcome of the patients was evaluated using the Musculoskeletal Tumor Society (MSTS) functional scoring system for the lower extremities.
RESULTS: The mean age was 38 (9-80) years at the time of primary surgery. Pathological fracture was the presentation in 28 patients. The study included 44 patients with primary bone tumor and 16 patients with a secondary bone tumor. The mean MSTS functional score of the patients was 24.3 (range, 18-30) points with no significant difference in patients with primary or secondary tumors. The rate of complications in the present series was 45%. The most frequent complication was an infection in 10 patients (16.7%), followed by aseptic loosening in 7 patients (11.7%). Local recurrence of primary bone tumors occurred in three out of 44 patients (6.8%).
CONCLUSION: Modular bipolar tumor prosthesis has a good long-term functional result in both primary and secondary tumors of the proximal femur, with no significant effect of age, presence or absence of pathological fracture or femoral resection length on the functional outcome. It was found that the only statistically significant variable regarding the risk of infection is previous surgeries. LEVEL OF EVIDENCE: Level IV, retrospective case series.
© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bipolar tumor prosthesis; Malignant bone tumors; Proximal femur; Resection

Mesh:

Year:  2020        PMID: 32851502     DOI: 10.1007/s00402-020-03581-6

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  3 in total

Review 1.  Surgical treatment for metastatic disease of the pelvis and the proximal end of the femur.

Authors:  T A Damron; F H Sim
Journal:  Instr Course Lect       Date:  2000

2.  Functional and radiographic outcome after tumor limb salvage surgery using STANMORE megaprostheses.

Authors:  A F Mavrogenis; E A Mitsiokapa; V I Sakellariou; G Tzanos; P J Papagelopoulos
Journal:  J BUON       Date:  2011 Apr-Jun       Impact factor: 2.533

3.  Surgical treatment of metastatic femoral fractures: achieving an improved quality of life for cancer patients.

Authors:  Masashi Morishige; Keiichi Muramatsu; Yasuhiro Tominaga; Takahiro Hashimoto; Toshihiko Taguchi
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

  3 in total
  2 in total

1.  Comparative Analysis of Two Surgical Treatment Options for Giant Cell Tumor of the Proximal Femur: Extended Curettage and Segmental Resection.

Authors:  Yuhao Yuan; Qing Liu; Yupeng Liu; Ziyi Wu; Wei Zhong; Hongbo He; Wei Luo
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

2.  Is bipolar hemiarthroplasty an appropriate type of hip articulation following proximal femoral or total femoral resections for musculoskeletal malignancies?

Authors:  Fevzi Saglam; Ozgur Baysal; Evrim Sirin; Omer Sofulu; Mehmet Deniz Kesimer; Bulent Erol
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-06       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.